Simon F.S. Li Marine Science Laboratory, School of Life Sciences, The Chinese University of Hong Kong, Room 201A, Science Park Road, Shatin, N.T., Hong Kong, SAR, China.
Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China.
Clin Rev Allergy Immunol. 2019 Aug;57(1):55-73. doi: 10.1007/s12016-017-8647-y.
Food allergy imposes a severe global health burden, and thus, there is a dire need for safe and effective treatments. Allergen-specific immunotherapy (AIT) is currently the only approach to restore immune tolerance through administrating increasing doses of allergen extracts. Unfortunately, the development of AIT for food allergies has been impeded by the frequent anaphylactic side effects during the course of treatment. The emergence of component-resolved diagnosis has greatly improved our ability to identify causative allergens and revolutionized the design of AIT. Molecular features such as IgE-binding epitopes and T cell epitopes have been elucidated in most major food allergens, inspiring the use of multiple strategies to manipulate the allergens and design safer alternatives to AIT. Although these allergen-modifying approaches are currently restricted to preclinical characterization and animal studies, the employment of these strategies has certainly paved the way for improving the safety of existing AIT. A safe and effective AIT for food allergy is not far beyond reach.
食物过敏对全球健康造成严重负担,因此,我们迫切需要安全有效的治疗方法。过敏原特异性免疫疗法(AIT)是目前唯一通过给予递增剂量的过敏原提取物来恢复免疫耐受的方法。不幸的是,食物过敏的 AIT 发展受到治疗过程中频繁发生过敏反应的阻碍。成分解析诊断的出现极大地提高了我们识别致病过敏原的能力,并彻底改变了 AIT 的设计。大多数主要食物过敏原的 IgE 结合表位和 T 细胞表位的分子特征已经阐明,这启发了使用多种策略来操纵过敏原并设计更安全的 AIT 替代品。虽然这些过敏原修饰方法目前仅限于临床前特征描述和动物研究,但这些策略的应用肯定为提高现有 AIT 的安全性铺平了道路。一种安全有效的食物过敏 AIT 已经近在咫尺。